Today sponge

Last updated

The Today sponge is a brand of plastic contraceptive sponge saturated with a spermicide nonoxynol-9 to prevent conception. [1] While initially popular in the 1980s in the United States, it is no longer commercially available as of 2019. [2] [3]

Contents

History

The Today sponge dates back to 1976 when it was created by Bruce Ward Vorhauer. [4] Vorhauer struggled for seven years to get the device approved and on the market. Following U.S. Food and Drug Administration (FDA) approval, [5] the brand was rolled out in June 1981. [6] The product, manufactured by VLI Corp. of Irvine, California, was classified as "relatively safe" by the FDA in 1984. [7] [8] A 1984 study in the American Journal of Obstetrics and Gynecology compared it with the diaphragm and found that the Today sponge was a "safe and acceptable method of contraception with an effectiveness rate in the range of other vaginal contraceptives." [9] [10] [11]

The Today sponge "was manufactured until 1995, when FDA imposed new manufacturing standards." [12] The product had several setbacks while marketed, including a link to toxic shock syndrome. [13] Personal financial problems forced Vorhauer to sell the entire manufacturing operation to American Home Products, now Wyeth. Almost the entire content of the facility was moved to the Whitehall-Robbins facility in Hammonton, New Jersey, from its original California home. The sponge was removed from the U.S. market in 1994 after problems were found at the facility related to the deionized water system. The water system, which was originally sized for much larger production, could not produce the small amounts of deionized water required for this one product and became repeatedly contaminated. Based on slumping sales and to avoid any further FDA issues, Wyeth stopped selling the sponge rather than move production or modify its plant.

In 1998, Allendale Pharmaceuticals acquired the rights to the Today sponge and it was once again available. [14] New FDA standards for manufacturing and record-keeping forced repeated delays, but the Today sponge was finally re-introduced in Canada in March 2003, and in the U.S. in September 2005. In January 2007, Allendale Pharmaceuticals was acquired by Synova Healthcare, Inc. [15] In December 2007 Synova filed for bankruptcy reorganization; [16] in 2008 the manufacturing rights to the Today sponge were purchased by Alvogen. In mid May 2009, Mayer Laboratories, Inc., the distributor of the Today sponge for the US, Canada and the EU, announced the Today sponge had been re-launched in the United States. [17] [18] [19]

At the end of 2019, Mayer Labs had issues with the equipment to manufacturer the Today sponge. As of the onset of the COVID pandemic, it is out of production with no information as to "when or if this situation will change." [3]

A 1995 Seinfeld episode, "The Sponge", revolved around Elaine's attempts to procure her favorite form of birth control, the discontinued Today sponge, and her rationing them based on whether a potential partner was "sponge-worthy". [20] This was later revisited in the series finale when the pharmacist testifies against Elaine for buying a case of sponges.

Related Research Articles

<span class="mw-page-title-main">Emergency contraception</span> Birth control measures taken after sexual intercourse

Emergency contraception (EC) is a birth control measure, used after sexual intercourse to prevent pregnancy.

<span class="mw-page-title-main">Dalkon Shield</span> Form of Intrauterine Device(IUD)

The Dalkon Shield was a contraceptive intrauterine device (IUD) developed by the Dalkon Corporation and marketed by the A.H. Robins Company. The Dalkon Shield was found to cause severe injury to a disproportionately large percentage of women, which eventually led to numerous lawsuits, in which juries awarded millions of dollars in compensatory and punitive damages.

<span class="mw-page-title-main">Diaphragm (birth control)</span> Cervical barrier type of birth control

The diaphragm is a barrier method of birth control. It is moderately effective, with a one-year failure rate of around 12% with typical use. It is placed over the cervix with spermicide before sex and left in place for at least six hours after sex. Fitting by a healthcare provider is generally required.

<span class="mw-page-title-main">Nonoxynol-9</span> Chemical compound

Nonoxynol-9, sometimes abbreviated as N-9, is an organic compound that is used as a surfactant. It is a member of the nonoxynol family of nonionic surfactants. N-9 and related compounds are ingredients in various cleaning and cosmetic products. It is widely used in contraceptives for its spermicidal properties.

Spermicide is a contraceptive substance that destroys sperm, inserted vaginally prior to intercourse to prevent pregnancy. As a contraceptive, spermicide may be used alone. However, the pregnancy rate experienced by couples using only spermicide is higher than that of couples using other methods. Usually, spermicides are combined with contraceptive barrier methods such as diaphragms, condoms, cervical caps, and sponges. Combined methods are believed to result in lower pregnancy rates than either method alone.

<span class="mw-page-title-main">Cervical cap</span> Form of barrier contraception

The cervical cap is a form of barrier contraception. A cervical cap fits over the cervix and blocks sperm from entering the uterus through the external orifice of the uterus, called the os.

<span class="mw-page-title-main">Levonorgestrel</span> Hormonal medication used for birth control

Levonorgestrel is a hormonal medication which is used in a number of birth control methods. It is combined with an estrogen to make combination birth control pills. As an emergency birth control, sold under the brand names Plan B One-Step and Julie, among others, it is useful within 72 hours of unprotected sex. The more time that has passed since sex, the less effective the medication becomes, and it does not work after pregnancy (implantation) has occurred. Levonorgestrel works by preventing ovulation or fertilization from occurring. It decreases the chances of pregnancy by 57–93%. In an intrauterine device (IUD), such as Mirena among others, it is effective for the long-term prevention of pregnancy. A levonorgestrel-releasing implant is also available in some countries.

Levonorgestrel-releasing implant, sold under the brand name Jadelle among others, are devices that release levonorgestrel for birth control. It is one of the most effective forms of birth control with a one-year failure rate around 0.05%. The device is placed under the skin and lasts for up to five years. It may be used by women who have a history of pelvic inflammatory disease and therefore cannot use an intrauterine device. Following removal, fertility quickly returns.

<span class="mw-page-title-main">Contraceptive patch</span> Transdermal patch applied to prevent pregnancy

A contraceptive patch, also known as "the patch", is a transdermal patch applied to the skin that releases synthetic oestrogen and progestogen hormones to prevent pregnancy. They have been shown to be as effective as the combined oral contraceptive pill with perfect use, and the patch may be more effective in typical use.

Extended or continuous cycle combined oral contraceptive pills are a packaging of combined oral contraceptive pills (COCPs) that reduce or eliminate the withdrawal bleeding that would occur once every 28 days in traditionally packaged COCPs. It works by reducing the frequency of the pill-free or placebo days. Extended cycle use of COCPs may also be called menstrual suppression, although other hormonal medications or medication delivery systems may also be used to suppress menses. Any brand of combined oral contraceptive pills can be used in an extended or continuous manner by simply discarding the placebo pills; this is most commonly done with monophasic pills in which all of the pills in a package contain the same fixed dosing of a synthetic estrogen and a progestin in each active pill.

<span class="mw-page-title-main">Comparison of birth control methods</span>

There are many methods of birth control that vary in requirements, side effects, and effectiveness. As the technology, education, and awareness about contraception has evolved, new contraception methods have been theorized and put in application. Although no method of birth control is ideal for every user, some methods remain more effective, affordable or intrusive than others. Outlined here are the different types of barrier methods, hormonal methods, various methods including spermicides, emergency contraceptives, and surgical methods and a comparison between them.

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

Ortho Pharmaceutical was initially formed in the United States in 1931 as a subsidiary of Johnson & Johnson to market the first prescription spermicidal contraceptive jelly, Ortho-Gynol.

<span class="mw-page-title-main">Mestranol/noretynodrel</span> Combined oral contraceptive medication

Mestranol/norethynodrel was the first combined oral contraceptive pill (COCP) being mestranol and norethynodrel. It sold as Enovid in the United States and as Enavid in the United Kingdom. Developed by Gregory Pincus at G. D. Searle & Company, it was first approved on June 10, 1957, by the U.S. Food and Drug Administration for treatment of menstrual disorders. The FDA approved an additional indication for use as a contraceptive on June 23, 1960, though it only became legally prescribable nationwide and regardless of the woman's marital status after Eisenstadt v. Baird in 1972. In 1961, it was approved as a contraceptive in the UK and in Canada.

<span class="mw-page-title-main">Contraceptive implant</span> Implantable medical device used for birth control

A contraceptive implant is an implantable medical device used for the purpose of birth control. The implant may depend on the timed release of hormones to hinder ovulation or sperm development, the ability of copper to act as a natural spermicide within the uterus, or it may work using a non-hormonal, physical blocking mechanism. As with other contraceptives, a contraceptive implant is designed to prevent pregnancy, but it does not protect against sexually transmitted infections.

<span class="mw-page-title-main">Birth control</span> Method of preventing human pregnancy

Birth control, also known as contraception, anticonception, and fertility control, is the use of methods or devices to prevent unintended pregnancy. Birth control has been used since ancient times, but effective and safe methods of birth control only became available in the 20th century. Planning, making available, and using human birth control is called family planning. Some cultures limit or discourage access to birth control because they consider it to be morally, religiously, or politically undesirable.

<span class="mw-page-title-main">Womb veil</span>

The womb veil was a 19th-century American form of barrier contraception consisting of an occlusive pessary, i.e. a device inserted into the vagina to block access of the sperm into the uterus. Made of rubber, it was a forerunner to the modern diaphragm and cervical cap. The name was first used by Edward Bliss Foote in 1863 for the device he designed and marketed. "Womb veil" became the most common 19th-century American term for similar devices, and continued to be used into the early 20th century. Womb veils were among a "range of contraceptive technology of questionable efficacy" available to American women of the 19th century, forms of which began to be advertised in the 1830s and 1840s. They could be bought widely through mail-order catalogues; when induced abortion was criminalized during the 1870s, reliance on birth control increased. Womb veils were touted as a discreet form of contraception, with one catalogue of erotic products from the 1860s promising that they could be "used by the female without danger of detection by the male."

<span class="mw-page-title-main">Wyeth</span> American pharmaceutical company

Wyeth Pharmaceuticals Inc. was a pharmaceutical company until it was purchased by Pfizer in 2009. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger.

<span class="mw-page-title-main">CONRAD (organization)</span> Nonprofit organization in Arlington, United States

CONRAD is a non-profit scientific research organization that works to improve global and reproductive health, particularly in women in developing countries. CONRAD was established in 1986 under a cooperative agreement between Eastern Virginia Medical School (EVMS) and the United States Agency for International Development (USAID). CONRAD’s products are developed primarily for women in low-resource settings, in that they are designed to be safe, affordable and user-friendly. CONRAD is led by Scientific and Executive Director Gustavo F. Doncel, M.D., Ph.D. Primary funding for CONRAD comes from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development (USAID), with additional funding from The Bill & Melinda Gates Foundation and the National Institutes of Health (NIH).

<span class="mw-page-title-main">Combined hormonal contraception</span> Form of hormonal contraception combining both an estrogen and a progestogen

Combined hormonal contraception (CHC), or combined birth control, is a form of hormonal contraception which combines both an estrogen and a progestogen in varying formulations.

References

  1. Lockerm, Sari (2005). Today Sponge. The Complete Idiot's Guide to Amazing Sex, p. 367. Penguin, ISBN   978-1-59257-327-1
  2. Day, Kathleen (January 22, 1985). VLI to Begin Marketing `Today' Sponge in Britain. Los Angeles Times
  3. 1 2 "Out of Stock". todaysponge.com. 2019. Archived from the original on April 26, 2010. Retrieved 20 May 2023.
  4. Emmons, Steve (February 15, 1993). The final fall. Los Angeles Times
  5. FDA's approval of the Today contraceptive sponge: hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, July 13, 1983
  6. Granelli, James S. (October 19, 1985). VLI Reports. Los Angeles Times
  7. Day, Kathleeen (November 13, 1984). VLI Contraceptive Sponge 'Relatively Safe,' Says FDA. Los Angeles Times
  8. Millenson, Michael L. (January 12, 1984). Sales soar for firm's Today sponge contraceptives. Chicago Tribune
  9. Edelman DA, McIntyre SL, Harper J (1984). A comparative trial of the Today contraceptive sponge and diaphragm. American Journal of Obstetrics and Gynecology 1984 Dec 1;150(7):869-76. PMID   6095664
  10. Edelman DA, North BB (1987). Parity and the effectiveness of the Today contraceptive sponge. Adv Contracept. 1987 Dec;3(4):327-33. PMID   3445801
  11. Berger KL, Remington K (1987). The prophylactic properties of the Today sponge and other spermicide containing contraceptives. Adv Contracept. 1987 Jun;3(2):125-31. PMID   2820207
  12. Schuiling, Kerri Durnell and Likis, Frances E. (2006). Jones & Bartlett Learning, ISBN   978-0-7637-4717-6
  13. Associated Press (December 7, 1983). Birth control device linked to toxic shock. The Free Lance-Star
  14. Rosenthal MS (2003). The Gynecological Sourcebook, p. 144. McGraw-Hill, ISBN   978-0-07-140279-8
  15. George, John (2007-01-16). "Synova Healthcare finds company worthy of purchase". Philadelphia Business Journal. Retrieved 2007-01-16.
  16. "Synova Healthcare, maker of contraceptive sponge filed for bankruptcy". December 19, 2007.
  17. "Today Sponge Returns To Store Shelves". Mayer Laboratories, Inc. 2009. Retrieved 2009-05-14.
  18. "Todays® Sponge Returns To Store Shelves". Alvogen, Inc. 2009. Retrieved 2022-09-22.
  19. "Mayer Labs Acquires Today(R) Sponge Distribution Rights". Biospace.com. 2009. Retrieved 2022-09-25.
  20. Lavery, David and Sara Lewis Dunne (2006). Seinfeld, master of its domain: revisiting television's greatest sitcom, p. 247. Continuum International Publishing Group, ISBN   978-0-8264-1803-6